Truist Securities Downgrades BioTelemetry (BEAT) to Hold; Sees Deal Going Through
Tweet Send to a Friend
Truist Securities analyst Kaila Krum downgraded BioTelemetry (NASDAQ: BEAT) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
